|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 4800 Deerwood Campus Parkway (DCC 2-2) |
Address2 |
|
| City | Jacksonville |
State | FL |
Zip Code | 32246 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 6382-12
|
||||||||
|
6. House ID# 314000000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Mai-Kim Norman |
Date | 4/20/2026 5:43:19 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues:
ACA Healthcare tax credits; Telehealth/ telehealth flexibilities; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP/Individual Market/ACA exchanges; Prior Authorization; Hospital Consolidation; Employer-provided health coverage; Cyber Attack/ Cyber Security; Community Health + Maternal Health; Hospital Billing; Anti-tiering, Anti-steering; Program integrity in the individual marketplace; Artificial Intelligence; Individual Market Reforms and eAPTC Extension; Health Savings Accounts; Direct to Consumer Marketing; Mental Health Parity Rule; Healthcare Affordability
Bills:
S.4027 - Healthy Competition for Better Care Act
To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.
Sponsor: Sen. Husted, Jon [R-OH]
H.R.6248 - Healthy Competition for Better Care Act
To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Rep. Arrington, Jodey C. [R-TX-19]
H.R.1909 - Preventing Maternal Deaths Reauthorization Act of 2025
To amend the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives, and for other purposes.
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R.1197 - PREEMIE Reauthorization Act of 2025
To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act.
Sponsor: Rep. Kelly, Robin L. [D-IL-2]
H.R.4710 - No Surprises Act Enforcement Act
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to increase penalties for group health plans and health insurance issuers for practices that violate balance billing requirements, and for other purposes.
Sponsor: Rep. Murphy, Gregory F. [R-NC-3]
S.2420 - No Surprises Act Enforcement Act
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to increase penalties for group health plans, health insurance issuers, and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes.
Sponsor: Sen. Marshall, Roger [R-KS]
H.R.3841 - Healthcare Cybersecurity Act of 2025
To enhance the cybersecurity of the Healthcare and Public Health Sector.
Sponsor: Rep. Crow, Jason [D-CO-6]
S.1851 - Healthcare Cybersecurity Act of 2025
To enhance the cybersecurity of the Healthcare and Public Health Sector.
Sponsor: Sen. Rosen, Jacky [D-NV]
S.2355 - Patients Deserve Price Tags Act
To amend the Public Health Service Act to provide for hospital and insurer price transparency.
Sponsor: Sen. Marshall, Roger [R-KS]
H.R.2509 - COMPLETE Care Act
To amend title XVIII of the Social Security Act to provide incentives for behavioral health integration.
Sponsor: Rep. Malliotakis, Nicole [R-NY-11]
S.931 - COMPLETE Care Act
To amend title XVIII of the Social Security Act to provide incentives for behavioral health integration.
Sponsor: Sen. Cortez Masto, Catherine [D-NV]
S.958 - Tech to Save Moms Act
To support the use of technology in maternal health care, and for other purposes.
Sponsor: Sen. Lujan, Ben Ray [D-NM]
H.R.5629 - To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder, except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
Sponsor: Rep. Houchin, Erin [R-IN-9]
H.R.1627 - TREATS Act
To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes.
Sponsor: Rep. Norcross, Donald [D-NJ-1]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Labor - Dept of (DOL)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
Giles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues:
Same-day billing restrictions in Medicaid; Medicare Advantage & MA Rate Notice; Medicare/Transparency; Mental Health Care, Youth Mental Health; Site neutral payment reform; MA Reform
Bills:
H.R.5746 - Addressing Whole Health in Medicare Advantage Act (118th)
To amend title XVIII of the Social Security Act to expand the availability of supplemental benefits to certain Medicare Advantage enrollees.
Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
H.R. 7996, Improving CARE for Youth Act (118th)
To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day.
Sponsor: Rep. Dunn, Neal P. [R-FL-2]
S.2556 - Improving CARE for Youth Act (118th)
To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day.
Sponsor: Sen. Carper, Thomas R. [D-DE]
S.1105 - No UPCODE Act
To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage.
Sponsor: Sen. Cassidy, Bill [R-LA]
H.R.4077 - GUARD Veterans Health Care Act
To amend title 38, United States Code, and the Social Security Act to permit recovery from the Department of Veterans Affairs of costs from Medicare Advantage and Medicare prescription drug plans and to modify the authority for recovery by the United States of reasonable charges for certain care or services furnished to veterans for non-service-connected disabilities, and for other purposes.
Sponsor: Rep. Doggett, Lloyd [D-TX-37]
S.2145 - GUARD Veterans Health Care Act
To amend title 38, United States Code, and the Social Security Act to permit recovery from the Department of Veterans Affairs of costs from Medicare Advantage and Medicare prescription drug plans and to modify the authority for recovery by the United States of reasonable charges for certain care or services furnished to veterans for non-service-connected disabilities, and for other purposes.
Sponsor: Sen. Warren, Elizabeth [D-MA]
H.R.668 - Coordinating Care for Senior Veterans and Wounded Warriors Act
To require the Secretary of Veterans Affairs to carry out a pilot program to coordinate, navigate, and manage care and benefits for veterans enrolled in both the Medicare program and the system of annual patient enrollment of the Department of Veterans Affairs.
Sponsor: Rep. Ciscomani, Juan [R-AZ-6]
S.506 - Coordinating Care for Senior Veterans and Wounded Warriors Act
This bill requires the Department of Veterans Affairs (VA) to implement a three-year pilot program to coordinate, navigate, and manage care and benefits for veterans who are enrolled in both the Medicare program and the VA health care system.
Sponsor: Sen. Moran, Jerry [R-KS]
H.R.842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Sponsor: Rep. Arrington, Jodey C. [R-TX-19]
H.R.1227 - Alternatives to PAIN Act
To amend title XVIII of the Social Security Act to ensure appropriate access to non-opioid pain management drugs under part D of the Medicare program.
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1]
H.R.1510 - Due Process Continuity of Care Act
To amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes.
Sponsor: Rep. Turner, Sylvester [D-TX-18]
H.R.7324 - More Behavioral Health Providers Act of 2026
To amend title XVIII of the Social Security Act to expand eligibility for incentives under the Medicare health professional shortage area bonus program to practitioners furnishing mental health and substance use disorder services.
Sponsor: Rep. Budzinski, Nikki [D-IL-13]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Labor - Dept of (DOL), White House Office, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
Giles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Issues:
Generics access; Prescription Drug Cost; Step Therapy
Bills:
S.1954 - Biosimilar Red Tape Elimination Act
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
Sponsor: Sen. Lee, Mike [R-UT]
S.3014 - Ensuring Timely Access to Generics Act of 2025
To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.
Sponsor: Sen. Shaheen, Jeanne [D-NH]
S.1041 - Affordable Prescriptions for Patients Act
A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.
Sponsor: Sen. Cornyn, John [R-TX]
S.1040 - Drug Competition Enhancement Act
A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
Sponsor: Sen. Cornyn, John [R-TX]
S.1096 - Preserve Access to Affordable Generics and Biosimilars Act
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
Sponsor: Sen. Klobuchar, Amy [D-MN]
S.1095 - Stop STALLING Act
A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
Sponsor: Sen. Klobuchar, Amy [D-MN]
S.1097 - Interagency Patent Coordination and Improvement Act of 2025
To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
Sponsor: Sen. Durbin, Richard J. [D-IL]
H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025
To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
Sponsor: Rep. Neguse, Joe [D-CO-2]
S.2658 - Medication Affordability and Patent Integrity Act
To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
S.1302 - Increasing Transparency in Generic Drug Applications Act
To provide for increased transparency in generic drug applications.
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
H.R.1843 - Increasing Transparency in Generic Drug Applications Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Sponsor: Rep. Dunn, Neal P. [R-FL-2]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), White House Office, Labor - Dept of (DOL), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
Giles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |